Trial
NCT04807777
Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Columbia University
Collaborators
Incyte Corporation
Condition
Advanced Cutaneous Squamous Cell Carcinoma
Intervention
Ruxolitinib
Why stopped
Departure of the original investigator
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-27